209 results on '"Degos, Laurent"'
Search Results
2. Arsenic-Induced PML Targeting onto Nuclear Bodies: Implications for the Treatment of Acute Promyelocytic Leukemia
3. The "Zero Risk" Concept for Hospital-Acquired Infections: A Risky Business!
4. Breaking the mould in patient safety
5. Can France Keep Its Patients Happy?
6. Adverse events in medicine: Easy to count, complicated to understand, and complex to prevent
7. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
8. Evolving Characteristics and Outcome of Secondary Acute Promyelocytic Leukemia (APL): A Prospective Analysis by the French-Belgian-Swiss APL Group
9. PLZF-RARα Fusion Proteins Generated from the Variant t(11;17)(q23;q 21) Translocation in Acute Promyelocytic Leukemia Inhibit Ligand-Dependent Transactivation of Wild-Type Retinoic Acid Receptors
10. Altered Binding of Regulatory Factors to HLA Class I Enhancer Sequence in Human Tumor Cell Lines Lacking Class I Antigen Expression
11. HLA Class I Molecules are Associated with CD1a Heavy Chains on Normal Human Thymus Cells
12. Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
13. Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients
14. PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia
15. All trans retinoic acid in acute promyelocytic leukemia
16. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient
17. Foreword
18. Viewing the safety imperative from the French policy perspective
19. Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers
20. All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications
21. Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia Group
22. Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study
23. Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse
24. Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec®) in vitro and in vivo
25. Arsenic Trioxide Induces Apoptosis of Cutaneous T Cell Lymphoma Cells: Evidence for a Partially Caspase-Independent Pathway and Potentiation by Ascorbic Acid (Vitamin C)
26. THE HISTORY OF ACUTE PROMYELOCYTIC LEUKAEMIA
27. Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic Leukemia
28. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
29. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
30. Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia
31. Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia
32. Suitability of three indicators measuring the quality of coordination within hospitals
33. Differentiation Therapy for Acute Promyelocytic Leukemia
34. Neutrophilic Dermatoses During Granulocytopenia
35. A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia
36. Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia
37. Acute Promyelocytic Leukemia
38. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome
39. Treatment of acute promyelocytic leukaemia
40. Medical Progress: Acute Promyelocytic Leukemia
41. TCR γδ Bearing T Lymphocytes Infiltrating Human Primary Cutaneous Melanomas
42. HLA DQB1*0301 Allele is Involved in the Susceptibility to Erythema Multiforme
43. Dose effect of cis- and trans-encoded HLA-DQ-alpha-beta heterodimers in IDDM susceptibility
44. A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
45. Extensive genomic polymorphism in mouse 21-hydroxylase region
46. Serological expression after sequential double transfection with purified HLA-11 gene of mouse fibroblasts carrying human beta-2 microglobulin
47. Correlation between an HLA-DQα length polymorphism of messenger RNA and serologically defined specificities (DQwl, DRw53, DR3 + 5)
48. Real and apparent H-2-specific antibodies induced by syngeneic immunization
49. Intermolecular complexes between three human CD1 molecules on normal thymus cells
50. H-2 typing of mice genetically selected for high or low antibody production
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.